These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15565422)

  • 1. [Diagnosis of endolymphatic hydrops using low frequency modulated distortion product otoacoustic emissions].
    Hirschfelder A; Gossow-Müller-Hohenstein E; Hensel J; Scholz G; Mrowinski D
    HNO; 2005 Jul; 53(7):612-7. PubMed ID: 15565422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aural fullness and endolymphatic hydrops].
    Gossow-Müller-Hohenstein E; Hirschfelder A; Scholz G; Mrowinski D
    Laryngorhinootologie; 2003 Feb; 82(2):97-101. PubMed ID: 12624836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison of Distortion Product Otoacoustic Emission Properties in Ménière's Disease Patients and Normal-Hearing Participants.
    Drexl M; Krause E; Gürkov R
    Ear Hear; 2018; 39(1):42-47. PubMed ID: 28671918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the differential diagnosis of Ménière's disease using low-frequency acoustic biasing of the 2f1-f2 DPOAE.
    Brown DJ; Gibson WP
    Hear Res; 2011 Dec; 282(1-2):119-27. PubMed ID: 21944944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distortion-product otoacoustic emissions and glycerol testing in endolymphatic hydrops.
    Magliulo G; Cianfrone G; Triches L; Altissimi G; D'Amico R
    Laryngoscope; 2001 Jan; 111(1):102-9. PubMed ID: 11192876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis of endolymphatic hydrops with low tone masked otoacoustic emissions].
    Nubel K; Kabudwand E; Scholz G; Mrowinski D
    Laryngorhinootologie; 1995 Nov; 74(11):651-6. PubMed ID: 8561815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal fast fluctuations of electrocochleography and otoacoustic emissions in Menière's disease.
    Gerenton G; Giraudet F; Djennaoui I; Pavier Y; Gilain L; Mom T; Avan P
    Hear Res; 2015 Sep; 327():199-208. PubMed ID: 26232527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of three methods of using transtympanic electrocochleography for the diagnosis of Meniere's disease: click summating potential measurements, tone burst summating potential amplitude measurements, and biasing of the summating potential using a low frequency tone.
    Iseli C; Gibson W
    Acta Otolaryngol; 2010; 130(1):95-101. PubMed ID: 19396716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proof of endolymphatic hydrops].
    Hoth S
    HNO; 2005 Jul; 53(7):597-9. PubMed ID: 15971049
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of glycerol test in Meniere's disease with pure tone audiometry and distortion product otoacoustic emission].
    Jabłonka A; Pośpiech L; Orendorz-Fraczkowska K
    Otolaryngol Pol; 2003; 57(5):731-7. PubMed ID: 14994621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early diagnosis of endolymphatic hydrops with distortion. Product otoacoustic emissions.
    Magliulo G; Cianfrone G; Di Cello P; Tersigni A
    An Otorrinolaringol Ibero Am; 2004; 31(2):173-89. PubMed ID: 15185614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in otoacoustic emission during the glycerol test in the ears of patients with Meniere's disease].
    Sakashita T; Kubo T; Kyunai K; Ueno K; Hikawa C; Shibata T; Yamane H; Kusuki M; Wada T; Uyama T
    Nihon Jibiinkoka Gakkai Kaiho; 2001 Jun; 104(6):682-93. PubMed ID: 11494522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-frequency distortion product otoacoustic emission test compared to ECoG in diagnosing endolymphatic hydrops.
    Rotter A; Weikert S; Hensel J; Scholz G; Scherer H; Hölzl M
    Eur Arch Otorhinolaryngol; 2008 Jun; 265(6):643-9. PubMed ID: 18026744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase-dependent suppression of transient evoked and distortion product otoacoustic emissions by a low-frequency tone.
    Scholz G; Mrowinski D; Hensel J
    Audiology; 1999; 38(5):271-5. PubMed ID: 10548375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vestibular evoked myogenic potentials and distortion-product otoacoustic emissions combined with glycerol testing in endolymphatic hydrops: their value in early diagnosis.
    Magliulo G; Cianfrone G; Gagliardi M; Cuiuli G; D'Amico R
    Ann Otol Rhinol Laryngol; 2004 Dec; 113(12):1000-5. PubMed ID: 15633904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electrocochleography and phase audiometry in diagnosis of Meniere disease].
    Anft D; Jamali Y; Scholz G; Mrowinski D
    HNO; 2001 Feb; 49(2):102-8. PubMed ID: 11270191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous otoacoustic emissions in humans with endolymphatic hydrops.
    Haginomori SI; Makimoto K; Tanaka H; Araki M; Takenaka H
    Laryngoscope; 2001 Jan; 111(1):96-101. PubMed ID: 11192908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An alternative diagnostic test for active Ménière's disease and cochlear hydrops using high-pass noise masked responses: the complex amplitude ratio.
    Don M; Kwong B; Tanaka C
    Audiol Neurootol; 2007; 12(6):359-70. PubMed ID: 17664867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of endolymphatic hydrops by low-frequency masking.
    Mrowinski D; Scholz G; Krompass S; Nubel K
    Audiol Neurootol; 1996; 1(2):125-34. PubMed ID: 9390796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.